UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Alnylam Pharmaceuticals is implementing good security practices.
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.
This report shows a preliminary security rating for Alnylam Pharmaceuticals. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
Protected health information (PHI) is any information about health status, provision of health care ...
While cyber security and information security are generally used as synonyms, there are key ...
Compare Alnylam Pharmaceuticals's security performance with other companies